Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
1.350
+0.010 (0.75%)
At close: Apr 28, 2026, 4:00 PM EDT
1.440
+0.090 (6.67%)
After-hours: Apr 28, 2026, 7:56 PM EDT
Dogwood Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 6.1 | 8.7 | 3.72 | 4.25 | 4.85 | |
| Research & Development | 21.87 | 3.53 | 1.73 | 8.07 | 10.8 | |
| Operating Expenses | 27.97 | 12.23 | 5.45 | 12.32 | 15.64 | |
| Operating Income | -27.97 | -12.23 | -5.45 | -12.32 | -15.64 | |
| Interest Expense | - | -0.09 | - | - | - | |
| Interest & Investment Income | 0.1 | - | 0.15 | 0.07 | 0.01 | |
| Currency Exchange Gain (Loss) | -0.03 | -0.03 | - | - | - | |
| EBT Excluding Unusual Items | -27.9 | -12.35 | -5.3 | -12.25 | -15.64 | |
| Gain (Loss) on Sale of Assets | -0 | - | - | - | - | |
| Legal Settlements | - | - | - | - | -0.33 | |
| Other Unusual Items | -6.13 | - | - | - | - | |
| Pretax Income | -34.04 | -12.35 | -5.3 | -12.25 | -15.96 | |
| Income Tax Expense | 0.22 | -0 | - | - | - | |
| Net Income | -34.26 | -12.35 | -5.3 | -12.25 | -15.96 | |
| Preferred Dividends & Other Adjustments | 1.26 | 0.51 | - | - | - | |
| Net Income to Common | -35.51 | -12.86 | -5.3 | -12.25 | -15.96 | |
| Shares Outstanding (Basic) | 5 | 1 | 1 | 0 | 0 | |
| Shares Outstanding (Diluted) | 5 | 1 | 1 | 0 | 0 | |
| Shares Change (YoY) | 384.29% | 36.84% | 69.62% | 32.91% | 69.06% | |
| EPS (Basic) | -7.13 | -12.52 | -7.05 | -27.66 | -47.90 | |
| EPS (Diluted) | -7.13 | -12.52 | -7.05 | -27.66 | -48.00 | |
| EBITDA | -27.97 | -12.22 | - | - | - | |
| D&A For EBITDA | 0 | 0.01 | - | - | - | |
| EBIT | -27.97 | -12.23 | -5.45 | -12.32 | -15.64 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.